University of Washington spinout Split Biosciences raises $1.2M to commercialize SPLiT-seq single‑cell RNA sequencing

Split Biosciences, a University of Washington spinout founded by Charlie Roco, Alex Rosenberg, and Georg Seelig, raised a $1.2 million seed round to commercialize SPLiT-seq, a faster, higher-throughput single-cell RNA sequencing method that uses combinatorial barcoding to avoid physical cell isolation.

No comments yet.